BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8239903)

  • 21. Synthesis and properties of amides of 1-benzyl-3-methyl- and 1-butyl-3-phenyl-7-methyl-4-oxo-2-thioxo (2,4-dioxo)-1,2,3,4-tetrahydropyrido-[2,3-d]pyrimidine-6-carboxy lic acids.
    Sladowska H; Zawisza T
    Farmaco Sci; 1986 Dec; 41(12):954-63. PubMed ID: 3556569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of derivatives of hydrazinopyrimidines with carbonyl compounds.
    Pelova R; Spassovska N; Maneva L; Golovinsky E
    Pharmazie; 1984 Apr; 39(4):270-1. PubMed ID: 6739531
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiviral compounds. X. Synthesis and anti-influenza virus activity of 2-substituted 5-alkyl-6-hydroxy-4-methylpyrimidines (author's transl)].
    Nishimura T; Miyamoto Y; Fukuyasu H
    Yakugaku Zasshi; 1976 Mar; 96(3):384-7. PubMed ID: 986456
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyrimidines as the chemotherapeutic drugs.
    Cieplik J; Królicki ZA
    Acta Pol Pharm; 1992; 49(4):59-66. PubMed ID: 16092437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological investigations of some novel thiazolylbenzimidazoles, and benzimidazolyl-thiazolo[4,5-d]pyrimidines.
    Habib NS; Rida SM; Badawey EA; Fahmy HT; Ghozlan HA
    Pharmazie; 1997 May; 52(5):346-50. PubMed ID: 9183785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunomodulatory properties of 2-C-methyl-D-erythritol-2,4-cyclopyrophosphate and search for its new derivatives].
    Potapov VD; Biketov SF; Demina GR; Lysak EI; Titareva GM; Bakhteeva IV; Ostrovskiĭ DN
    Prikl Biokhim Mikrobiol; 2001; 37(3):274-8. PubMed ID: 11443893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.
    Traxler P; Bold G; Frei J; Lang M; Lydon N; Mett H; Buchdunger E; Meyer T; Mueller M; Furet P
    J Med Chem; 1997 Oct; 40(22):3601-16. PubMed ID: 9357527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new and efficient synthesis of pyrrolo[2,3-d]pyrimidine anticancer agents: Alimta (LY231514, MTA), homo-Alimta, TNP-351, and some aryl 5-substituted pyrrolo[2,3-d]pyrimidines.
    Taylor EC; Liu B
    J Org Chem; 2003 Dec; 68(26):9938-47. PubMed ID: 14682686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone.
    Brough PA; Barril X; Borgognoni J; Chene P; Davies NG; Davis B; Drysdale MJ; Dymock B; Eccles SA; Garcia-Echeverria C; Fromont C; Hayes A; Hubbard RE; Jordan AM; Jensen MR; Massey A; Merrett A; Padfield A; Parsons R; Radimerski T; Raynaud FI; Robertson A; Roughley SD; Schoepfer J; Simmonite H; Sharp SY; Surgenor A; Valenti M; Walls S; Webb P; Wood M; Workman P; Wright L
    J Med Chem; 2009 Aug; 52(15):4794-809. PubMed ID: 19610616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety.
    Hafez HN; El-Gazzar AR
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4143-7. PubMed ID: 19540114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polycyclic azines with heteroatoms in the 1- and 3-position. 40. Synthesis of heterocyclic immunomodulators. 2. 3-Mercaptoalkylthieno(2,3-d)pyrimidine-2,4(1H,3H)-diones: synthesis and testing of immunostimulant activity].
    Gütschow M; Drössler K; Leistner S
    Arch Pharm (Weinheim); 1995 Mar; 328(3):231-4. PubMed ID: 7763139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (6-methyl-2-methylsulfanyl-4-oxo-3,4-dihydro-3-pyrimidinyl)acetic acid and related compounds exhibiting anti-inflammatory activity.
    Jakubkiene V; Burbuliene MM; Udrenaite E; Garaliene V; Vainilavicius P
    Pharmazie; 2002 Sep; 57(9):610-3. PubMed ID: 12369447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antibacterial properties of 1,2,3-aryl-1,2,3,4-tetrahydropyrimido[4,5-d]pyrimidine derivatives.
    Cieplik J; Raginia M; Pluta J; Gubrynowicz O; Bryndal I; Lis T
    Acta Pol Pharm; 2008; 65(4):427-34. PubMed ID: 19051583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological properties of N,N-dialkyl(dialkenyl)amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylic acid.
    Sladowska H; Sabiniarz A; Filipek B; Kardasz M; Maciag D
    Farmaco; 2003 Jan; 58(1):25-32. PubMed ID: 12595034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis and biological properties of amides of 4-arylamino-2-hydroxy-6-methyl-5-pyrimidino-carboxylic acids].
    Machoń Z; Długosz A
    Acta Pol Pharm; 1983; 40(1):1-6. PubMed ID: 6880814
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and anticancer properties of pyrimido[4,5-b]quinolines.
    Długosz A; Duś D
    Farmaco; 1996 May; 51(5):367-74. PubMed ID: 8767847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.